News About: Pharm. Industry
Lilly Korea opens wellness call center
Lilly Korea says it has opened its wellness call center to ensure a healthy balance of the mind-body and spirit that results in an overall feeling of well-being in patients with mental disorder.
According to the co...
Kwangdong to market new radiosensitizer in 2012
Kwangdong Pharm says it has signed an exclusive lisensing agreement with China-based Shandong Luye Pharmaceutical (SDLY) to develop and market a novel radiosensitizer “CMNa” in Korea.
CMNa is a new nitroimidazole ...
Government to cut antihypertensive drug price
The government said it is considering reducing prices of antihypertensive drugs through price re-evaluation program, aside from the cost-effective evaluation of insurance-covered medicines.
The government will eval...
Sales of domestic 10 leading drug manufacturers take up 38.3% in ethical market
The 10 major pharmaceutical manufacturing firms in May marked the combined market share of 38.3 percent in domestic prescription medicines market, up 2.9 percent from the same month of last year.
The domestic ethic...
Can Prigrel be viable in anti-clotting market?
Sanofi Aventis’s Plavix is truly far ahead of Korea generic markers in the domestic anti-clotting market in terms of market share, however, Chong Kun Dang Pharmaceutical is hoping to challenge its competitors with its...
Government to toughen drug related safety regulations
The government plans to strengthen the regulations of adverse drug reaction from next month as part of its efforts to collect more cases of drug related side effects during re-examination of new drugs and postmarketin...
Green Cross to market medicine for irritable bowel syndrome, Algiron
Green Cross Corporation entered into an exclusive agreement with Boehringer Ingelheim Korea over Algiron (cimetropium bromide).
Under the agreement, GCC will market the new antimuscarinic compound in Korea on an ex...
LG’s Utropin adds indication for SGA
LG Life Sciences says the Korea Food and Drug Administration has recently approved an additional indication of Utropin, a growth hormone, for the treatment of small for gestational age (SGA).
SGA is a term used to ...
Korea recalls Sanofi Aventis' enoxaparin after OSCS contamination
The Korea Food and Drug Administration has recently recalled one batch of the anticoagulant medicine Clexane (enoxaparin) which has been found to contain the contaminant over-sulphated chondroitin sulphate (OSCS).
...
Green Cross wins NGSP Level I
Green Cross Reference Lab. said on June 12 it has acquired Level I certification from the National Glycohemoglobin Standardization Program (NGSP) for the first time in Korea.
The NGSP offers three types of certific...
